Mon, March 1, 2021

Joshua Schimmer Upgraded (BMRN) to Buy and Increased Target to $100 on, Mar 1st, 2021

Joshua Schimmer of Evercore ISI Group, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Buy and Increased Target from $90 to $100 on, Mar 1st, 2021.

Joshua has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Joshua's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joshua


  • Joseph Schwartz of "SVB Leerink" Reiterated at Buy with Decreased Target to $108 on, Friday, November 6th, 2020